← United States · Coverage record
US · SEC FORM 4
NovoCure Ltd
NVCR · Nasdaq · CIK 0001645113 · Healthcare · Medical Devices
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
21 Form 4 transaction lines observed in the same window
8 sales · 13 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 6 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-09-05 · Cordova Ashley.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 11,163,094
- Previous report
- 11,796,425
- Avg daily volume
- 1,110,466
- Days to cover
- 10.1
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-09-05 | Cordova Ashley | Purchase (P) | Ordinary Shares | 81,550 | USD 12.22 | USD 996,541 | SEC filing ↗ |
| 2025-07-29 | Brackmann Christoph | Purchase (P) | Ordinary Shares | 20,000 | USD 11.59 | USD 231,800 | SEC filing ↗ |
| 2021-11-26 | Danziger Asaf | Purchase (P) | Ordinary Shares | 4,974 | USD 102.44 | USD 509,539 | SEC filing ↗ |
| 2020-09-02 | Shah Pritesh | Purchase (P) | Ordinary Shares | 4,200 | USD 85.01 | USD 357,042 | SEC filing ↗ |
Form 4 evidence
63 transaction lines in the latest 365-day window; 773 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Puri Michal Nath | Award / grant (A) | Ordinary Shares | 1,905 | USD 11.15 | USD 21,241 | SEC filing ↗ |
| 2026-06-30 | Leonard Frank X | Award / grant (A) | Ordinary Shares | 1,905 | USD 11.15 | USD 21,241 | SEC filing ↗ |
| 2026-06-30 | Danziger Asaf | Award / grant (A) | Ordinary Shares | 268 | USD 11.15 | USD 2,988 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Puri Michal Nath | Award / grant (A) | Ordinary Shares | 1,905 | USD 11.15 | USD 21,241 | SEC filing ↗ |
| 2026-06-30 | Leonard Frank X | Award / grant (A) | Ordinary Shares | 1,905 | USD 11.15 | USD 21,241 | SEC filing ↗ |
| 2026-06-30 | Danziger Asaf | Award / grant (A) | Ordinary Shares | 268 | USD 11.15 | USD 2,988 | SEC filing ↗ |
| 2026-06-30 | Ben Arye Barak | Award / grant (A) | Ordinary Shares | 1,299 | USD 11.15 | USD 14,484 | SEC filing ↗ |
| 2026-06-04 | Leonard Frank X | Sale (S) | Ordinary Shares | 34,273 | USD 17.93 | USD 614,515 | SEC filing ↗ |
| 2026-06-03 | VERNON W ANTHONY | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Stafford Kristin | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Scannell Timothy J | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Ocean Allyson J | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Madden Martin J. | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | LEUNG GABRIEL | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Hung David | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | HILLEMAN JERYL L | Award / grant (A) | Ordinary Shares | 11,610 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-02 | VERNON W ANTHONY | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-06-02 | Stafford Kristin | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-06-02 | Scannell Timothy J | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-06-02 | Ocean Allyson J | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-06-02 | LEUNG GABRIEL | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-06-02 | Hung David | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-06-02 | HILLEMAN JERYL L | Sale (S) | Ordinary Shares | 2,945 | USD 15.77 | USD 46,443 | SEC filing ↗ |
| 2026-04-28 | VERNON W ANTHONY | Option exercise / conversion (M) | Ordinary Shares | 21,500 | USD 11.39 | USD 244,885 | SEC filing ↗ |
| 2026-03-05 | Paravasthu Mukund | Sale (S) | Ordinary Shares | 43,246 | USD 13.77 | USD 595,497 | SEC filing ↗ |
| 2026-03-04 | Weinberg Uri | Sale (S) | Ordinary Shares | 6,412 | USD 13.31 | USD 85,344 | SEC filing ↗ |
| 2026-03-04 | Puri Michal Nath | Sale (S) | Ordinary Shares | 1,100 | USD 13.31 | USD 14,641 | SEC filing ↗ |
| 2026-03-04 | Paravasthu Mukund | Sale (S) | Ordinary Shares | 5,377 | USD 13.31 | USD 71,568 | SEC filing ↗ |
| 2026-03-04 | Leupin Nicolas | Sale (S) | Ordinary Shares | 1,100 | USD 13.31 | USD 14,641 | SEC filing ↗ |
| 2026-03-04 | Leonard Frank X | Sale (S) | Ordinary Shares | 5,607 | USD 13.31 | USD 74,629 | SEC filing ↗ |
| 2026-03-04 | Cordova Ashley | Tax withholding (F) | Ordinary Shares | 17,638 | USD 13.30 | USD 234,585 | SEC filing ↗ |
| 2026-03-04 | Brackmann Christoph | Sale (S) | Ordinary Shares | 6,412 | USD 13.31 | USD 85,344 | SEC filing ↗ |
| 2026-03-03 | Weinberg Uri | Award / grant (A) | Ordinary Shares | 50,125 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | NVCR |
| CIK | 0001645113 |
| Sector | Healthcare |
| Industry | Medical Devices Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 773 transaction lines from 2020-01-08 to 2026-06-30 8 P purchase lines · 457 S sale lines · 308 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.